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Guest Editorial
Neurobiology of Pediatric Mood Disorders: Part II
Jean A. Frazier, M.D. and Jair C. Soares, M.D.
This is the second of two issues of Journal of Child andAdolescent Psychopharmacology with a special focus on
mood disorders in youth. The overall theme of this two-part
series is to highlight recent advances in the field in terms of
understanding the phenomenology, the neurobiology, and
the treatment of major depression, chronic irritability, and
bipolar disorder (BP) in children and adolescents. This issue
further extends the work published in the December 2008
issue.
Carlson et al. summarize the Research Forum that took
place at the 2006 Annual Meeting of the American Academy
of Child and Adolescent Psychiatry. The goal of the forum
was to formulate a research agenda for early-onset BP and to
improve its outcome by understanding both risk and pro-
tective factors. One of the most essential recommendations
that came out of the forumwas that the field needs to establish
a consensus on the definition and diagnosis of BP in youth.
Establishing diagnostic consensus and assessment ap-
proaches will lay the foundation for the study of genetics,
biology, and treatment and will aid in the identification of
mediators and moderators of early-onset BP.
In keeping with the recommendations of the research
agenda outlined in the article by Carlson and colleagues, two
papers (Olvera et al. and Diler et al.) focus on the assessment
of youth with BP. Finding the appropriate tools to aid in the
identification of children with the disorder is of significant
interest given the ongoing controversy regarding the diag-
nosis of BP in youth and the extraordinary heterogeneity of
the clinical phenotype. Olvera and colleagues tackle the crit-
ical issue of the assessment of personality traits in children
and adolescents with BP. They compared temperament and
character traits in youths with BP as assessed by the Junior
Temperament and Character Inventory compared to healthy
controls. Interestingly, they found that youth with BP had
higher scores on novelty seeking, harm avoidance, and fan-
tasy. In addition, those with BP had lower scores on other
measures (e.g., self directedness, reward dependence, per-
sistence, and cooperativeness). Their paper contributes to
disentangling the differences between temperament and
psychopathology in early-onset BP. However, many ques-
tions remain regarding the cart before the horse—are these
personality traits due to the illness or do these personality
traits predispose individuals to BP? Only future studies will
help us in this regard. The paper by Diler and colleagues is
equally compelling but with a different focus. These authors
evaluated the usefulness of the Child Behavior Checklist
(CBCL) to identify children below the age of 12 years enrolled
in the Course and Outcome for Bipolar Disorder in Youth
(COBY) study who had the diagnosis of BP. Prior reports
indicated that the sum of attention, aggression, and anxious=
depression subscales (CBCL-BPD) of the CBCL may have
some specificity for pediatric BP. However, these authors
found that while children with BP had more severe psycho-
pathology than healthy controls and psychiatric controls, the
CBCL-BPD phenotype was more frequently present but was
not specific to BP children. This paper highlights the chal-
lenges of finding a screening tool to help aid in the diagnosis
of early-onset BP.
Four papers in this issue involve the use of neuroimaging
(Lopez-Larson et al., Mueller et al., Chang et al., and Dickstein
et al.). Lopez-Larson and colleagues use anatomic imaging to
determine if youth with unmodified Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV) BP and co-
morbid attention-deficit=hyperactivity disorder (ADHD) have
brain-imaging findings unique to the co-morbid presentation
or similar to the findings in children with BP who do not have
ADHD. Interestingly, the youth with the co-morbid presenta-
tion shared neurobiologic markers with the BP alone group
and did not share findings with the ADHD group, suggest-
ing that those with BPþADHD may not constitute a true co-
morbidity but may be a subtype of BP. Mueller and colleagues
assess hippocampal function using fMRI in boys with familial
male precocious puberty (FMPP-excess testosterone). Boys
with FMPP performed differently than unaffected controls;
specifically, there were differences in hippocampal activation
in response to fearful faces. This particular paper provides an
elegant model for studying the influence of sex hormones on
cognitive and affective brain development.
Those attending the research forum in 2006 recommended
wrapping neuroimaging studies around treatment trials as a
way of further assessing treatment response and adverse ef-
fects and two of the papers in this issue fulfill this research
agenda. The first study is by Chang and colleagues, and it
examines the effects of divalproex treatment on the structure,
chemistry and function of specific brain regions in children at
high risk for BP. The results of this study were essentially
negative; however, despite the small sample size there was a
degree of decreased prefrontal brain activation that correlated
with improvement of depression. The second study, by
Dickstein et al., evaluated lithium via a randomized placebo-
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controlled trial in youth with severe mood dysregulation
and looked at changes in magnetic resonance spectroscopy
(MRS) patterns. This study is the first double-blind placebo-
controlled trial completed in this particular group of children.
Unfortunately, overall lithium did not significantly improve
their mood symptoms, and the MRS outcome measures were
negative. However, both of these wrap-around studies were
likely hampered by insufficient numbers, and this highlights
the need for multisite studies that combine treatment with
neuroimaging in order to enhance the numbers of patients
enrolled and to assure that adequate power is achieved. A
multisite design would be in keeping with the recommenda-
tions that came out of the 2006 Research Forum.
Finally, there are two treatment studies and one case report
included in this special issue. Pavuluri and colleagues eval-
uated the effectiveness and safety of open trial lamotrigine in
the maintenance of manic and depressive symptoms in
youths with BP. Lamotrigine was initially titrated to a thera-
peutic dose while the patients were stabilized on atypical
antipsychotics. During the final 6 weeks, patients were on
lamotrigine monotherapy. The response rates were notable
for both manic and depressive symptoms, and the remission
rate was 56% at the end of 14 weeks. The second study by
Redden and colleagues looked at the long-term safety of di-
valproex ER in youth with bipolar I disorder. This was an
open-label study that was 6 months in duration. The number
of subjects in this study was quite substantial (n¼ 226). One
hundred and nine subjects completed the study. This study
fulfills at least two of the recommendations from the Research
Forum in that it is a longer-term study with a large number of
subjects. In general, the medication waswell tolerated and the
most common adverse events were weight gain, nausea, and
increased appetite. Finally, a case report by Kul and col-
leagues, which describes maintenance lithium treatment in an
adolescent, is included.
In summary, the papers in this issue provide information
regarding assessment tools for the evaluation of temperament
and symptoms, they provide important neurobiologic infor-
mation, and add to the literature on the treatment of mood
disorders. Collectively, these articles begin to tackle many of
the research agenda items set forth in the Research Forum
article by Carlson et al. at the beginning of this volume. We
thank our colleagues for their valuable research and their
important contributions to the field.
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